Skip to main content
. 2021 Mar 13;10(3):450. doi: 10.3390/antiox10030450

Figure 4.

Figure 4

AD-9308 treatment reduced 4-hydroxy-2-nonenal (4-HNE) levels and enhanced aldehyde dehydrogenase 2 (ALDH2) activities to protect streptozotocin (STZ)-induceddiabetic mice against oxidative stress. (a) Serum 4-HNE levels, (b) 4-HNE protein adducts, (c) ALDH2 activities, and (d) heme oxygenase-1 (Ho-1) protein expressions of cardiac tissues were measured in STZ-induced diabetic mice treated with 0, 60, 180 mg/kg/day of AD-9308 by oral gavages andnon-diabetic control mice. Data are presented as mean ± SEM (n = 6–12 per group). p-for-trend was used to test the linear trend.